Under the terms of the agreement, CompuMed will become a CMS value-added partner. It will employ its CardioGram system to provide remote cardiac screening for detainees at 68 correctional facilities that outsource health care services to CMS. The agreement with CMS extends CompuMed's dominance as a provider of remote ECG screening for the correctional market. Over the past two years, the company has announced long-term contracts with correctional departments in several states including New York, California and Nevada.
Based in St. Louis, CMS is a provider of comprehensive health care services for correctional systems, serving more than 300 jail and prison sites in 27 states. "We are delighted to join Correctional Medical Services' efforts to provide correctional facility clients with cost-efficient, quality health care", stated Jerry McLaughlin, CompuMed's CEO. "We believe this agreement establishes a solid foundation for our growing partnership with CMS."
CompuMed's traditional core business is providing remote ECG interpretation terminals and related services to medical facilities that may not have access to physicians trained and qualified to interpret ECG results. Customers for the company's CardioGram system are typically correctional facilities, ambulatory surgery centres, occupational health clinics and physicians' offices. The system reduces health care costs significantly by providing remote cardiac screening at the point-of-care. Another advantage is an optional feature that automatically sends ECG results to a trained cardiologist for an overread when the results are abnormal.
Correctional Medical Services (CMS) is the nation's premier provider of health care services to prisons and jails. With a presence in 27 states, CMS is truly the industry specialist in correctional health care. This expertise is based on CMS' ability to consistently meet and exceed customer expectations. CMS has more than 6000 employees and contract providers responsible for their success in providing character and expertise, traits that are vital and necessary in helping CMS provide a high standard of health care.
Founded in 1973, CompuMed Inc. is a provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate health care providers nationwide. More company news is available in the VMW July 2005 article CompuMed study demonstrates increased efficiency of DICOM OsteoGram over standard x-ray-based version.